106
total announcements
539678.BO · 15 min delayed
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has granted 1,17,000 employee stock options under the ESOP Scheme 2021, with an exercise price of ₹ 79 per share. The options are exercisable within a maximum period of 3 years from the date of vesting. The grant is in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has proposed the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 consecutive years, subject to shareholder approval at the upcoming Annual General Meeting.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹45.0 Cr, EBITDA of ₹-17.6 Cr, and PAT of ₹-5.3 Cr. The company has also announced the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 consecutive years.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd announced its unaudited financial results for Q1 FY27, with revenue at ₹45.0 Cr, EBITDA at ₹-17.6 Cr, and PAT at ₹-5.3 Cr. The company also announced the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 years. The company's registered office has been shifted within the same city limit, and the books of accounts have been kept at the corporate office.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has announced the allotment of 5332 ESOPs under the ESOP Scheme 2021, with shares to be credited to permanent ISIN upon final trading approval.
Quick Heal Technologies Ltd
Quick Heal Technologies Ltd has scheduled a board meeting on July 30, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.